SCHEMBL259544

SCHEMBL259544

c1cc2ncnn2cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL425579 0.82
SCHEMBL212241 0.65
SCHEMBL795326 0.64
SCHEMBL297724 0.64
SCHEMBL21621695 0.63 DYRK1A (0.44)
SCHEMBL334805 0.62
SCHEMBL5741141 0.62 DYRK1A (0.47)
SCHEMBL10767495 0.62 ALDH1A1 (0.36)
SCHEMBL21104073 0.62 DYRK1A (0.47)
SCHEMBL23143440 0.61 EGLN2 (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 512 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118215664-A Substituted triazoloheteroaryl compounds as USP1 inhibitors and uses thereof 上海瑛派药业有限公司 2024-06-18 CN claimed
US-20220194950-A1 TRIAZOLOPYRIMIDINES BASED ON THYMINE NUCLEOBASE AND METHODS FOR PRODUCING THEM TERA STONE CO., LTD (JP) 2022-06-23 US claimed
EP-3950064-A1 THYMINE NUCLEOBASE-BASED TRIAZOLOPYRIMIDINES AND PRODUCTION METHOD THEREFOR Tera Stone Co., Ltd (JP) 2022-02-09 EP claimed
US-20180153984-A1 ADJUVANT PARTICLES COMPRISING ADENOSINE RECEPTOR ANTAGONISTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-06-07 US claimed
US-20170189399-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-07-06 US claimed
WO-2016176558-A1 ADJUVANT PARTICLES COMPRISING ADENOSINE RECEPTOR ANTAGONISTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-11-03 WO claimed
US-8865711-B2 Phenylimidazole derivatives as PDE10A enzyme inhibitors H. LUNDBECK A/S (DK) 2014-10-21 US claimed
US-8796304-B2 Tricyclic imidazole compounds as PDE10 inhibitors H. LUNDBECK A/S (DK) 2014-08-05 US claimed
EP-2513107-B1 HETEROAROMATIC PHENYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS LUNDBECK & CO AS H (DK) 2014-07-30 EP claimed
EP-2513105-B1 2-ARYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS LUNDBECK & CO AS H (DK) 2014-05-14 EP claimed
EP-1544200-A1 1,2,4 -TRIAZOLO 1,5-c PYRIMIDINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-06-22 EP claimed
EP-1116722-B1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES KYOWA HAKKO KOGYO KK (JP) 2005-01-12 EP claimed
WO-2004080173-A2 SYNERGISTICALLY ACTING HERBICIDAL MIXTURES BASF AKTIENGESELLSCHAFT (DE) 2004-09-23 WO claimed
EP-0976753-B1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES KYOWA HAKKO KOGYO KK (JP) 2004-01-02 EP claimed
US-6545000-B1 Adenosine A2A receptor antagonists; treating Parkinson's disease KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-04-08 US claimed
EP-1116722-A1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-07-18 EP claimed
US-6222035-B1 AS ADENOSINE A.SUB.2A RECEPTOR ANTAGONISTS AND ARE USEFUL FOR THERAPY OR OR PROPHYLAXIS OF VARIOUS DISEASES INDUCED BY HYPERACTIVITY OF ADENOSINE A.SUB.2A RECEPTORS SUCH AS PARKINSON'S DISEASE, SENILE DEMENTIA OR DEPRESSION KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-04-24 US claimed
EP-0976753-A1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 2000-02-02 EP claimed
EP-0745154-B1 MULTICOMPONENT SYSTEM FOR MODIFYING, DECOMPOSING OR BLEACHING LIGNIN, LIGNIN-CONTAINING MATERIALS OR SIMILAR SUBSTANCES AND METHOD OF USING THIS SYSTEM LIGNOZYM GMBH (DE) 1998-09-16 EP claimed
EP-0263071-B1 2-Substituted-e-fused-[1,2,4]-triazolo[1,5-c] pyrimidines, pharmaceutical compositions, and uses thereof CIBA-GEIGY AG (CH) 1992-08-12 EP claimed